Access here alternative investment news about Boston Scientific To Spend $1.1B In Cash To Buy Lumentis Ltd's Surgical Business
Private Equity

Boston Scientific To Spend $1.1B In Cash To Buy Lumentis Ltd's Surgical Business

by marketwatch.com posted 1month ago 22 views
Boston Scientific Corp. announced Wednesday an agreement to buy the global surgical business of Lumenis LTD for $1.07 billion in cash from Baring Private Equity Asia. The medical technology company said Lumentis's surgical business includes laser systems, fibers and accessories used for urology and otolaryngology procedures, and is expected to have 2021 sales of about $200 million. "The MOSES laser technology, paired with our LithoVue(TM) Single-Use Digital Flexible Ureteroscope and comprehensive kidney stone management portfolio, will enable execution of our strategy for our stone franchise," said Meghan Scanlon, president of urology and pelvic health at Boston Scientific.

In this article